Management Team
Network Coordination
-
Ansgar W. Lohse
University Medical Centre Hamburg-Eppendorf, Germany
Paediatric lead
-
Marianne Hørby Jørgensen
Rigshospitalet University of Copenhagen, Denmark
Deputy Coordinator and Lead Clinical Patient Management System (CPMS)
-
Marcial Sebode
University Medical Centre Hamburg-Eppendorf, Germany
R-Liver Registry Lead
-
Christoph Schramm
University Medical Centre Hamburg-Eppendorf, Germany
Representatives of the hepatology societies (EASL & ESPGHAN)
-
Emmanuel Gonzales
Hôpital Bicêtre, Assistance Publique – Hôpitaux de Paris, France
ESPGHAN Representative
-
Virgínia Hernández Gea
Hospital Clínic i Provincial de Barcelona, Spain
EASL Representative
-
Marianne Hørby Jørgensen
Rigshospitalet (RH), Copenhagen university hospital
ESPGHAN Representative
Patient Leads
-
Angela Leburgue
ALBI France
-
José Willemse
Adult Patient Lead
Nederlandse Leverpatienten Vereniging, Netherlands
Training and Education Committee
-
Juan Carlos García-Pagán
Hospital Clínic i Provincial de Barcelona, Spain
-
-
Isabel Gonçalves
Centro Hospitalar Universitario de Coimbra, Portugal
-
Claus Petersen
Hannover Medical School, Germany
Scientific advisor
-
Emma Andersson
Karolinska University Hospital Stockholm, Sweden
Scientific advisor
Network Project Management
-
Sabina Bernhardt
Communication Officer
University Medical Centre Hamburg-Eppendorf, Germany
-
Juliane Gaenge
Project Manager
University Medical Centre Hamburg-Eppendorf, Germany
-
Hendrik Matthies
Project Manager
University Medical Centre Hamburg-Eppendorf, Germany
-
Laura Ruhkopf
Secretary
University Medical Centre Hamburg-Eppendorf, Germany
Transversal Working Groups - Leads
Quality of Life
-
Tom Gevers
Radboud University Medical Center Nijmegen
-
Marianne Samyn
King’s College Hospital London, UK
-
José Willemse
Adult Patient Lead
Nederlandse Leverpatienten Vereniging, Netherlands
Transition
-
Ruth De Bruyne
Ghent University Hospital, Belgium
-
Deirdre Kelly
Birmingham Children's Hospital NHS Foundation Trust, UK
-
João Madaleno
Centro Hospitalar Universitario de Coimbra, Portugal
-
Zoe Mariño
Hospital Clínic i Provincial de Barcelona, Spain
-
Karsten Vanden Wyngaert
Co-Lead
Ghent University Hospital, Belgium
-
José Willemse
Adult Patient Lead
Nederlandse Leverpatienten Vereniging, Netherlands
Liver Disease in Pregnancy
-
Wiebke Papenthin
Morbus Wilson e.V., Germany
-
Christina Weiler-Normann
University Medical Centre Hamburg-Eppendorf, Germany
Nurses Working Group Leads
-
Jen Clancy
Royal Free London NHS Foundation Trust, Hepatology CNS, UK
-
Martina Fellinghauer
Liver Care Nursing Austria, AKH Wien, Austria
-
Neus Llarch Alfonso
BCLC – Hepatic Oncology Unit – Hospital Clínic, Barcelona, Spain
-
Denise Schäfer
Liver Care Nursing Austria, Ordensklinikum Linz GmbH, Barmherzige Schwestern, Austria
Disease Working Groups - Leads
Primary Biliary Cholangitis (PBC)
-
Frederik Nevens
University Hospitals KULeuven, Belgium
-
Alessio Gerussi
ASST-Monza, Ospedale San Gerardo, Italy
-
Angela Leburgue
ALBI France
-
Adriaan van der Meer
Erasmus UMC Rotterdam, Netherlands
Autoimmune Hepatitis (AIH)
-
Marcial Sebode
University Medical Centre Hamburg-Eppendorf, Germany
-
Marianne Hørby Jørgensen
Rigshospitalet University of Copenhagen, Denmark
-
Vincenzo Ronca
University Hospitals Birmingham, UK
-
Bert Tomsin
Patiëntenvereniging Zeldzame Leverziekten, Belgium
-
José Willemse
Adult Patient Lead
Nederlandse Leverpatienten Vereniging, Netherlands
Primary sclerosing cholangitis (PSC)
-
Annika Bergquist
Karolinska University Hospital Stockholm, Sweden
-
Norman Junge
Hannover Medical School, Germany
-
Martine Walmsley
PSC support, UK; EASL Policy and Public Health Committee
Genetic Cholestatic Disease
-
Henkjan J. Verkade
University Medical Center Groningen, Netherlands
-
Emmanuel Gonzales
Hôpital Bicêtre, Assistance Publique – Hôpitaux de Paris, France
-
Verena Keitel
Otto-von-Guericke University Magdeburg, Germany
Biliary Atresia
-
Björn Fischler
Karolinska University Hospital Stockholm, Sweden
-
Claus Petersen
Hannover Medical School, Germany
Alpha-1 Antitrypsin Liver Disease (AATD)
-
Pavel Strnad
University Hospital Aachen, Germany
-
Mathias Ruiz
CHU Lyon, France
-
Frank Willersinn
Alpha-1 Plus asbl, Belgium
Acute Liver Failure
-
Dominic Lenz
Heidelberg University Hospital, Germany
-
José Willemse
Adult Patient Lead
Nederlandse Leverpatienten Vereniging, Netherlands
Polycystic liver disease
-
Joost P.H. Drenth
Radboud University Medical Center Nijmegen, Netherlands
-
Tess Harris
PKD Charity, UK
Vascular Liver Disease - VALDIG
-
Aurélie Plessier
Hôpital Beaujon, Assistance Publique – Hôpitaux de Paris, France
-
Valerie McLin
University Hospitals Geneva, Swiss Centre for Liver Disease in Children, Switzerland
Biliary Malformations
-
Janneke Bruggink
University Medical Center Groningen, Netherlands
-
Joost P.H. Drenth
Radboud University Medical Center Nijmegen, Netherlands
Wilson Disease
-
Wiebke Papenthin
Morbus Wilson e.V., Germany
-
Thomas Sandahl
Aarhus Universitetshospital, Denmark
-
Piotr Socha
Children's Memorial Health Institute, Warsaw
Rare Liver Tumours
-
Johann von Felden
University Medical Centre Hamburg-Eppendorf, Germany
-
Maria Reig
Hospital Clínic i Provincial de Barcelona, Spain
ERN RARE-LIVER Organisational Structure
The ERN RARE-LIVER Management Board
The ERN RARE-LIVER Management Board holds regular meetings to consult on the various activities. It is composed of members representing the following areas:
- Coordination
- Patient representation (ePAG)
- Clinical Patient Management System (CPMS)
- Registry
- Quality of Life
- Clinical practice guidelines
- The three rare liver disease pillars
- Hepatology societies (adult and paediatric)
- Basic research
- Project Management